BerganKDV Wealth Management, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 166 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
BerganKDV Wealth Management, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$12,900
-2.3%
10,0000.0%0.00%0.0%
Q1 2023$13,200
-12.0%
10,0000.0%0.00%
-50.0%
Q4 2022$15,000
+25.0%
10,0000.0%0.00%
+100.0%
Q3 2022$12,000
+9.1%
10,0000.0%0.00%0.0%
Q2 2022$11,000
-63.3%
10,0000.0%0.00%
-66.7%
Q1 2022$30,000
+11.1%
10,0000.0%0.00%0.0%
Q4 2021$27,000
+12.5%
10,000
+53.8%
0.00%0.0%
Q3 2021$24,000
-14.3%
6,5000.0%0.00%0.0%
Q2 2021$28,000
+27.3%
6,5000.0%0.00%0.0%
Q1 2021$22,000
-4.3%
6,5000.0%0.00%0.0%
Q4 2020$23,000
+43.8%
6,5000.0%0.00%0.0%
Q3 2020$16,000
+33.3%
6,5000.0%0.00%
+50.0%
Q2 2020$12,000
+200.0%
6,500
+160.0%
0.00%
+100.0%
Q1 2020$4,000
-20.0%
2,5000.0%0.00%0.0%
Q4 2019$5,0000.0%2,5000.0%0.00%0.0%
Q3 2019$5,000
-28.6%
2,5000.0%0.00%0.0%
Q2 2019$7,000
+16.7%
2,5000.0%0.00%0.0%
Q1 2019$6,0000.0%2,5000.0%0.00%0.0%
Q4 2018$6,000
-25.0%
2,5000.0%0.00%
-50.0%
Q3 2018$8,000
+14.3%
2,5000.0%0.00%0.0%
Q2 2018$7,0002,5000.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 9,105,691$30,140,0005.99%
Sio Capital Management, LLC 1,888,181$6,250,0003.50%
DAFNA Capital Management LLC 473,478$1,567,0001.32%
Cormorant Asset Management, LP 2,000,000$6,620,0000.96%
Ghost Tree Capital, LLC 1,100,000$3,641,0000.68%
Rhenman & Partners Asset Management AB 1,282,000$4,243,0000.67%
Palo Alto Investors LP 4,254,623$14,083,0000.67%
NEA Management Company, LLC 3,243,150$10,375,0000.36%
Telemetry Investments, L.L.C. 170,000$563,0000.25%
NJ State Employees Deferred Compensation Plan 355,000$1,175,0000.22%
View complete list of RIGEL PHARMACEUTICALS INC shareholders